Skip to main content
OpenTrials

Clinical trial condition

Non-Small-Cell Lung Carcinoma

Explore clinical trials studying Non-Small-Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

61 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Non-Small-Cell Lung Carcinoma trial results

Recruiting

A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea

NCT05703516

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • Novartis Investigative Site Daegu, Dalseo gu, South Korea
  • Novartis Investigative Site Suwon, Gyeonggi-do, South Korea
  • Novartis Investigative Site Incheon, Korea, South Korea
  • Novartis Investigative Site Seoul, Korea, South Korea
View Trial Details
Completed

Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)

NCT04738487

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Boca Raton Regional Hospital ( Site 0004) Boca Raton, Florida, United States
  • Illinois Cancer Care ( Site 0026) Peoria, Illinois, United States
  • Mercy Research - Cancer and Hematology Center ( Site 0032) Springfield, Missouri, United States
  • Mercy Research - David C. Pratt Cancer Center ( Site 0025) St Louis, Missouri, United States
View all 188 locations
View Trial Details
Completed

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT03088540

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Clinical Study Site Albury, New South Wales, Australia
  • Clinical Study Site Wollongong, New South Wales, Australia
  • Clinical Study Site Fitzroy, Australia
  • Clinical Study Site Minsk, Belarus
View all 192 locations
View Trial Details
Completed

Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)-Japan Extension Study

NCT03950674

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • National Hospital Organization Nagoya Medical Center ( Site 0324) Nagoya, Aichi-ken, Japan
  • Kurume University Hospital ( Site 0326) Kurume, Fukuoka, Japan
  • Hyogo Cancer Center ( Site 0325) Akashi, Hyōgo, Japan
  • Kanazawa University Hospital ( Site 0328) Kanazawa, Ishikawa-ken, Japan
View Trial Details
Completed

A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy

NCT02864251

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Pacific Shores Medical Group Long Beach, California, United States
  • Local Institution - 0029 Los Angeles, California, United States
  • Local Institution - 0033 Los Angeles, California, United States
  • Local Institution - 0061 Orange, California, United States
View all 109 locations
View Trial Details

Related conditions